These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10729776)

  • 61. Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis.
    Ehret A; Westendorp MO; Herr I; Debatin KM; Heeney JL; Frank R; Krammer PH
    J Virol; 1996 Sep; 70(9):6502-7. PubMed ID: 8709290
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death.
    Ramsdell F; Seaman MS; Miller RE; Picha KS; Kennedy MK; Lynch DH
    Int Immunol; 1994 Oct; 6(10):1545-53. PubMed ID: 7530039
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways.
    Vallejo AN; Schirmer M; Weyand CM; Goronzy JJ
    J Immunol; 2000 Dec; 165(11):6301-7. PubMed ID: 11086066
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cutting edge: Ly49A inhibits TCR/CD3-induced apoptosis and IL-2 secretion.
    Roger J; Chalifour A; Lemieux S; Duplay P
    J Immunol; 2001 Jul; 167(1):6-10. PubMed ID: 11418624
    [TBL] [Abstract][Full Text] [Related]  

  • 65. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A.
    Anel A; Buferne M; Boyer C; Schmitt-Verhulst AM; Golstein P
    Eur J Immunol; 1994 Oct; 24(10):2469-76. PubMed ID: 7523141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
    Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes.
    Brenner D; Golks A; Becker M; Müller W; Frey CR; Novak R; Melamed D; Kiefer F; Krammer PH; Arnold R
    Blood; 2007 Dec; 110(12):3968-77. PubMed ID: 17712048
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
    Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
    Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death.
    Schmitz I; Krueger A; Baumann S; Schulze-Bergkamen H; Krammer PH; Kirchhoff S
    J Immunol; 2003 Sep; 171(6):2930-6. PubMed ID: 12960316
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Apoptosis induced in T cells by human neuroblastoma cells: role of Fas ligand.
    Shurin GV; Gerein V; Lotze MT; Barksdale EM
    Nat Immun; 1998; 16(5-6):263-74. PubMed ID: 11061594
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differential susceptibility of naïve and activated human gammadelta T cells to activation-induced cell death by T-cell receptor cross-linking.
    Gan YH; Lui SS; Malkovsky M
    Mol Med; 2001 Sep; 7(9):636-43. PubMed ID: 11778653
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regulation of activation-induced cell death of mature T-lymphocyte populations.
    Janssen O; Sanzenbacher R; Kabelitz D
    Cell Tissue Res; 2000 Jul; 301(1):85-99. PubMed ID: 10928283
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The CD95/CD95L system as target for modulation of allogeneic immune responses].
    Schwinzer R; Dulat H; Kyas U; Wonigeit K
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):655-8. PubMed ID: 14518336
    [TBL] [Abstract][Full Text] [Related]  

  • 74. TCR stimulation protects CD8+ T cells from CD95 mediated apoptosis.
    Karas M; Zaks TZ; Yakar S; Dudley ME; LeRoith D
    Hum Immunol; 2001 Jan; 62(1):32-8. PubMed ID: 11165713
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signalling.
    Walker LS; McLeod JD; Boulougouris G; Patel YI; Ellwood CN; Hall ND; Sansom DM
    Immunology; 1999 Dec; 98(4):569-75. PubMed ID: 10594690
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antigen-induced T cell death is regulated by CD4 expression.
    Hamad AR; Schneck JP
    Int Rev Immunol; 2001 Oct; 20(5):535-46. PubMed ID: 11890611
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Activation-induced apoptosis of mature T cells is dependent upon the level of surface TCR but not on the presence of the CD3 zeta ITAM.
    She J; Matsui K; Terhorst C; Ju ST
    Int Immunol; 1998 Nov; 10(11):1733-40. PubMed ID: 9846702
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CD95 ligand (CD95L) in normal human lymphoid tissues: a subset of plasma cells are prominent producers of CD95L.
    Sträter J; Mariani SM; Walczak H; Rücker FG; Leithäuser F; Krammer PH; Möller P
    Am J Pathol; 1999 Jan; 154(1):193-201. PubMed ID: 9916933
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential and mutually exclusive expression of CD95 and CD95 ligand in epithelia of normal pancreas and chronic pancreatitis.
    Hasel C; Rau B; Perner S; Sträter J; Möller P
    Lab Invest; 2001 Mar; 81(3):317-26. PubMed ID: 11310825
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM.
    Giordano C; De Maria R; Stassi G; Todaro M; Richiusa P; Giordano M; Testi R; Galluzzo A
    Diabetologia; 1995 Dec; 38(12):1449-54. PubMed ID: 8786019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.